AMO 5G femtosecond laser cleared by FDA

The FDA has cleared the iFS Advanced Femtosecond Laser (AMO), which is now available for order.

The FDA has cleared the iFS Advanced Femtosecond Laser (AMO), which is now available for order.

The fifth generation laser, which can cut a corneal flap within 10 seconds, includes IntraLase-Enabled Keratoplasty (IEK), and has a higher repetition rate and tighter spot separation than earlier models. It has a unique inverted bevel-in-side cut angle to improve the biomechanical stability of postoperative corneas, and can create an elliptical flap to increase the number of surgical options.

The iFS laser - part of AMO's proprietary iLASIK technology suite - has an ergonomic design, new contemporary user interface and high-resolution digital video microscope, all designed to increase surgeon comfort and ease of operating, enhancing the outcome for the patient.

Related Videos
Trukera Medical rebranding ushers in new era of expansion into cornea market
Investigators report positive visual outcomes one year after monocular implantation of small aperture IOL
Investigating better indications and outcomes in laser refractive surgery
Avoiding errors when converting to DMEK
Related Content
© 2023 MJH Life Sciences

All rights reserved.